MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
40 hedge funds and large institutions have $55.2M invested in Merrimack Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+2
Holders Change %
+5.26%
% of All Funds
0.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
7
Reduced
10
Closed
4
Calls
$3.31M
Puts
$474K
Net Calls
+$2.84M
Net Calls Change
+$2.32M
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$1.84M |
| 2 |
NM
Newtyn Management
New York
|
+$1.74M |
| 3 |
Two Sigma Advisers
New York
|
+$1.52M |
| 4 |
Renaissance Technologies
New York
|
+$1.22M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$604K |
